Drug Shortage Report for RAN-TADALAFIL

Last updated on 2019-02-01 History
Report ID 31242
Drug Identification Number 02452081
Brand name RAN-TADALAFIL
Common or Proper name RAN-TADALAFIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) TADALAFIL
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-11-30
Actual start date 2017-11-30
Estimated end date Unknown
Actual end date 2018-08-13
Shortage status Resolved
Updated date 2019-02-01
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-02-01 French Compare
v12 2019-02-01 English Compare
v11 2018-03-05 French Compare
v10 2018-03-05 English Compare
v9 2018-02-05 French Compare
v8 2018-02-05 English Compare
v7 2018-01-18 French Compare
v6 2018-01-18 English Compare
v5 2017-12-15 French Compare
v4 2017-12-15 English Compare
v3 2017-12-01 English Compare
v2 2017-11-30 French Compare
v1 2017-11-30 English Compare